These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model. Pillay NS; Kellaway LA; Kotwal GJ Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064 [TBL] [Abstract][Full Text] [Related]
29. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316 [TBL] [Abstract][Full Text] [Related]
30. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation. Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690 [TBL] [Abstract][Full Text] [Related]
31. Creating the mouse that roared. Emerson D Minn Med; 2001 May; 84(5):6-9. PubMed ID: 11398634 [No Abstract] [Full Text] [Related]
32. Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Hwang DY; Cho JS; Lee SH; Chae KR; Lim HJ; Min SH; Seo SJ; Song YS; Song CW; Paik SG; Sheen YY; Kim YK Exp Neurol; 2004 Mar; 186(1):20-32. PubMed ID: 14980807 [TBL] [Abstract][Full Text] [Related]
33. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test. Kulkarni AP; Pillay NS; Kellaway LA; Kotwal GJ Biogerontology; 2008 Dec; 9(6):405-20. PubMed ID: 18679819 [TBL] [Abstract][Full Text] [Related]
34. Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease. Zilberter M; Ivanov A; Ziyatdinova S; Mukhtarov M; Malkov A; Alpár A; Tortoriello G; Botting CH; Fülöp L; Osypov AA; Pitkänen A; Tanila H; Harkany T; Zilberter Y J Neurochem; 2013 Apr; 125(1):157-71. PubMed ID: 23241062 [TBL] [Abstract][Full Text] [Related]
35. The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Burdo JR; Chen Q; Calcutt NA; Schubert D Neurobiol Aging; 2009 Dec; 30(12):1910-7. PubMed ID: 18372080 [TBL] [Abstract][Full Text] [Related]
36. Mutations at codon 717 of the beta-amyloid precursor protein gene are a cause of Alzheimer's disease. Kumar S Indian J Exp Biol; 1992 Feb; 30(2):156. PubMed ID: 1521868 [No Abstract] [Full Text] [Related]
37. [Experimental models in Alzheimer's disease]. Manzano S; González J; Marcos A; Payno M; Villanueva C; Matías-Guiu J Neurologia; 2009 May; 24(4):255-62. PubMed ID: 19603296 [TBL] [Abstract][Full Text] [Related]
38. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396 [TBL] [Abstract][Full Text] [Related]
39. MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilins. Tachi N; Hashimoto Y; Matsuoka M Biochem J; 2012 Mar; 442(2):413-22. PubMed ID: 22115042 [TBL] [Abstract][Full Text] [Related]
40. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Lamb BT; Bardel KA; Kulnane LS; Anderson JJ; Holtz G; Wagner SL; Sisodia SS; Hoeger EJ Nat Neurosci; 1999 Aug; 2(8):695-7. PubMed ID: 10412057 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]